Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has announced key resolutions from its recent board meeting, including the approval to deposit temporarily idle proceeds as call deposits and changes to its registered address. The board unanimously approved these measures, ensuring compliance with relevant regulations. This move reflects Junshi’s strategic financial management as it continues to adapt and grow in the competitive biosciences sector.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.